Tirzepatide is currently being investigated in the SURMOUNT cardiovascular outcomes trial of adults with obesity
A Phase 2b trial of the GLP-1 drug liraglutide, reported at AAIC 2024, found that it may reduce shrinking in parts of the brain that control memory, learning, language and decision-making by nearly 50 percent compared to placebo
Additionally, CVD remains a leading cause of morbidity and mortality in type 1 diabetes
Henry Meds includes a board-certified health coach with the cost of medication
Molecules , 2020 Irritable Bowel Syndrome (IBS) IBS is marked by abnormal gut motility, inflammation, and hypersensitivity
Your dose may need to go upyour price won't, remaining flat at $149 monthly across all commitment tiers